oa SA Pharmaceutical Journal - Boniva®: once-monthly oral treatment for postmenopausal osteoporosis : drug info - new product focus

Volume 83, Issue 1
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Boniva® 150 mg tablets contain 150 mg ibandronic acid (ibandronate) per tablet. The tablets are indicated for the treatment of osteoporosis in postmenopausal women in order to reduce the risk of vertebral fractures.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error